"
Team:UFMG Brazil/Cardbio
From 2013.igem.org
(Difference between revisions)
| Line 5: | Line 5: | ||
The main goal is to detect each of these biomarkers using our engineered E. coli by integrating the signals CFP, YFP and RFP produced when BNP, IMA and TMAO, respectively, are present in a sample of patient serum. This diagnosis is based on color intensity of the fluorescent proteins. So, we can establish the presence or absence and severity of ACS disease and predict earlier a myocardial event, thus providing information for fast treatment. | The main goal is to detect each of these biomarkers using our engineered E. coli by integrating the signals CFP, YFP and RFP produced when BNP, IMA and TMAO, respectively, are present in a sample of patient serum. This diagnosis is based on color intensity of the fluorescent proteins. So, we can establish the presence or absence and severity of ACS disease and predict earlier a myocardial event, thus providing information for fast treatment. | ||
===Project description=== | ===Project description=== | ||
| + | ===Project description2=== | ||
| + | ===Project description3=== | ||
Revision as of 21:52, 19 September 2013
